
VectorBuilder, Inc.
VectorBuilder | Revolutionize Gene Delivery from Research to Therapy
San Francisco, United States · $57.0M raised
- Headquarters
- San Francisco
- Website
- vectorbuilder.com
- Total Funding
- $57.0M
- Last Round
- $57.0M Series COct 2022
- Rounds
- 1
About
VectorBuilder is a Leading Provider of Recombinant Vectors and Viruses, Offering a Wide Range Gene Delivery Solutions Tailored to Your Project Needs.
Summary
VectorBuilder, Inc. is a Biotech company based in San Francisco, United States. It has raised $57.0M in total across 1 round, most recently a $57.0M Series C round in Oct 2022. Investors include Legend Capital and Guangzhou Yuexiu Industrial Investment Fund Management.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2022
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company